Life Scientist > Biotechnology

Research project to produce fish-free omega-3

27 October, 2026

SCU researchers are investigating how to grow omega-3-producing microorganisms more cheaply through precision fermentation.


Biotech manufacturing facility opens in Brisbane

26 October, 2026

ENTRI, a purpose-built multimodal facility which will enable biotech companies to manufacture products onsite, is now officially open in Brisbane.


Biodegradable smart patch can detect and treat blood clots

26 October, 2026

Researchers have developed a biodegradable smart patch that detects pressure changes and releases blood clot-dissolving medication when activated by ultrasound.


Cancer drug enters clinical trials based on a false mechanism

13 October, 2026

A cancer drug currently being tested in patients appears to have entered clinical trials based on an incorrect understanding of how it works.


Terumo K-Pack Embrace active safety needle

09 October, 2026

The K-Pack Embrace active safety needle is packaged in a rigid cap and case container, designed to protect the needle through the product life cycle until the point of use.


Could this 'nanobone' material allow children to regrow bone?

30 September, 2026

Australian scientists believe they have found an alternative to invasive bone graft procedures in children — procedures that have changed little in over 50 years.


Existing medicines could help treat deadly childhood dementia

24 September, 2026

Australian researchers have identified several existing TGA‑approved medicines that could help slow brain damage in children with a rare form of dementia.


mRNA therapy found to prevent recurrence of melanoma

21 August, 2026

Merck and Moderna have announced positive topline results from their Phase 3 trial of a personalised mRNA skin cancer therapy.


High doses of fertility drug linked to pregnancy risks

14 August, 2026

High doses of clomiphene citrate, accumulated over multiple fertility treatment cycles, could increase the risk of pregnancy loss.


Bird flu vaccine to be rolled out to "priority" species

12 August, 2026 by Lauren Davis

The Australian Government has announced the imminent rollout of a vaccine to protect some of Australia's most vulnerable native birds from the H5 bird flu.


Breast augmentation procedure uses 3D-printed scaffolds

11 August, 2026

3D-printed scaffold technology from medtech company BellaSeno has been used in a primary breast augmentation procedure at Macquarie University as part of a pivotal trial.


Could 'fusion proteins' reduce errors in a promising gene-editing tool?

08 May, 2026

Gene-editing tool CRISPR-Cas9 is used, among many things, to engineer new cancer immunotherapies. Now, Australian scientists believe they've made it safer.


Ecopha Biotech announces strategic cross-border model

01 May, 2026

To commercialise its ecopha.bio technology for a Pongamia-based bioeconomy, Australian company Ecopha Biotech has announced an Australia–India strategy.


$96m RNA Research and Manufacturing Facility opens in NSW

30 April, 2026

The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University Innovation Precinct will produce new and existing RNA therapeutics.


Cartherics and Catalent announce enhanced partnership

23 April, 2026

To support immune cell therapy products for the treatment of cancer and endometriosis, Australian biotech Cartherics has announced an enhanced partnership with Catalent.


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd